» Articles » PMID: 38725036

Development and Validation of a Predictive Model for the Risk of Sarcopenia in the Older Adults in China

Overview
Journal Eur J Med Res
Publisher Biomed Central
Specialty General Medicine
Date 2024 May 9
PMID 38725036
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sarcopenia is a progressive age-related disease that can cause a range of adverse health outcomes in older adults, and older adults with severe sarcopenia are also at increased short-term mortality risk. The aim of this study was to construct and validate a risk prediction model for sarcopenia in Chinese older adults.

Methods: This study used data from the 2015 China Health and Retirement Longitudinal Study (CHARLS), a high-quality micro-level data representative of households and individuals aged 45 years and older adults in China. The study analyzed 65 indicators, including sociodemographic indicators, health-related indicators, and biochemical indicators.

Results: 3454 older adults enrolled in the CHARLS database in 2015 were included in the final analysis. A total of 997 (28.8%) had phenotypes of sarcopenia. Multivariate logistic regression analysis showed that sex, Body Mass Index (BMI), Mean Systolic Blood Pressure (MSBP), Mean Diastolic Blood Pressure (MDBP) and pain were predictive factors for sarcopenia in older adults. These factors were used to construct a nomogram model, which showed good consistency and accuracy. The AUC value of the prediction model in the training set was 0.77 (95% CI = 0.75-0.79); the AUC value in the validation set was 0.76 (95% CI = 0.73-0.79). Hosmer-Lemeshow test values were P = 0.5041 and P = 0.2668 (both P > 0.05). Calibration curves showed significant agreement between the nomogram model and actual observations. ROC and DCA showed that the nomograms had good predictive properties.

Conclusions: The constructed sarcopenia risk prediction model, incorporating factors such as sex, BMI, MSBP, MDBP, and pain, demonstrates promising predictive capabilities. This model offers valuable insights for clinical practitioners, aiding in early screening and targeted interventions for sarcopenia in Chinese older adults.

Citing Articles

An explainable machine learning-based prediction model for sarcopenia in elderly Chinese people with knee osteoarthritis.

Wang Z, Zhou Y, Zeng X, Zhou Y, Yang T, Hu K Aging Clin Exp Res. 2025; 37(1):67.

PMID: 40053240 PMC: 11889032. DOI: 10.1007/s40520-025-02931-x.


Development and Validation of a Risk Prediction Model for Sarcopenia in Chinese Older Patients with Type 2 Diabetes Mellitus.

Wang X, Gao S Diabetes Metab Syndr Obes. 2024; 17:4611-4626.

PMID: 39635500 PMC: 11616483. DOI: 10.2147/DMSO.S493903.


An Artificial Intelligence Approach for Test-Free Identification of Sarcopenia.

Yin L, Zhao J J Cachexia Sarcopenia Muscle. 2024; 15(6):2765-2780.

PMID: 39513334 PMC: 11634523. DOI: 10.1002/jcsm.13627.

References
1.
Chen L, Woo J, Assantachai P, Auyeung T, Chou M, Iijima K . Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020; 21(3):300-307.e2. DOI: 10.1016/j.jamda.2019.12.012. View

2.
Cruz-Jentoft A, Landi F, Schneider S, Zuniga C, Arai H, Boirie Y . Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014; 43(6):748-59. PMC: 4204661. DOI: 10.1093/ageing/afu115. View

3.
Roberts R, Rhoades H, Vernon S . Using the CES-D scale to screen for depression and anxiety: effects of language and ethnic status. Psychiatry Res. 1990; 31(1):69-83. DOI: 10.1016/0165-1781(90)90110-q. View

4.
Springer J, Springer J, Anker S . Muscle wasting and sarcopenia in heart failure and beyond: update 2017. ESC Heart Fail. 2017; 4(4):492-498. PMC: 5695190. DOI: 10.1002/ehf2.12237. View

5.
Beaudart C, Dawson A, Shaw S, Harvey N, Kanis J, Binkley N . Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int. 2017; 28(6):1817-1833. PMC: 5457808. DOI: 10.1007/s00198-017-3980-9. View